Suchergebnisse - "Burhenne, Jürgen"

PubPharm (50)

1

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers

enthalten in: Clinical pharmacokinetics | 2024

von Rohr, B. | Krohmer, E. | Foerster, K. | +5

2

Effect of Tacrolimus Formulation (Prolonged-Release vs Immediate-Release) on Its Susceptibility to Drug-Drug Interactions with St. John's Wort

enthalten in: Clinical pharmacology in drug development | 2024

von Gümüs, K. | Teegelbekkers, A. | Sauter, M. | +6

3

Evaluation of Hydroxychloroquine as a Perpetrator on Cytochrome P450 (CYP) 3A and CYP2D6 Activity with Microdosed Probe Drugs in Healthy Volunteers

enthalten in: European journal of drug metabolism and pharmacokinetics | 2024

von Stoll, F. | Blank, A. | Mikus, G. | +7

4

Protocol of the IntenSify-Trial : An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy

enthalten in: Clinical and translational science | 2023

von Hohmann, N. | Sprick, M. | Pohl, M. | +19

5

CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately Predict Voriconazole Clearance in Healthy Adults

enthalten in: Clinical pharmacokinetics | 2023

von Muhareb, A. | Blank, A. | Meid, A. | +5

6

Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC

enthalten in: Nature cancer | 2023

von Zhou, X. | An, J. | Kurilov, R. | +23

7

Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion

enthalten in: Clinical pharmacokinetics | 2022

von Nassar, Y. | Hohmann, N. | Michelet, R. | +7

8

Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans

enthalten in: European journal of clinical pharmacology | 2022

von Elbe, A. | Foerster, K. | Blank, A. | +4

9

Early or deferred initiation of efavirenz during rifampicin-based TB therapy has no significant effect on CYP3A induction in TB-HIV infected patients

enthalten in: British journal of pharmacology | 2021

von Aklillu, E. | Zumla, A. | Habtewold, A. | +5

10

Application of Microdosed Intravenous Omeprazole to Determine Hepatic CYP2C19 Activity

enthalten in: Journal of clinical pharmacology | 2021

von Mahmoudi, M. | Foerster, K. | Burhenne, J. | +3

1
2
3
4
5
Nächster »
[5]